Yap MW - Search Results

1

HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase.

Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M. Goldstone DC, et al. Among authors: yap mw. Nature. 2011 Nov 6;480(7377):379-82. doi: 10.1038/nature10623. Nature. 2011. PMID: 22056990

2

SAMHD1 enhances nucleoside-analogue efficacy against HIV-1 in myeloid cells.

Ordonez P, Kunzelmann S, Groom HC, Yap MW, Weising S, Meier C, Bishop KN, Taylor IA, Stoye JP. Ordonez P, et al. Among authors: yap mw. Sci Rep. 2017 Feb 21;7:42824. doi: 10.1038/srep42824. Sci Rep. 2017. PMID: 28220857 Free PMC article.

3

Intracellular localisation of Fv1.

Yap MW, Stoye JP. Yap MW, et al. Virology. 2003 Mar 1;307(1):76-89. doi: 10.1016/s0042-6822(02)00053-3. Virology. 2003. PMID: 12667816 Free article.

4

Bending out and breaking away: host-cell accomplices in retroviral escape.

Yap MW, Stoye JP. Yap MW, et al. J Biol. 2003;3(1):3. doi: 10.1186/1475-4924-3-3. Epub 2003 Dec 19. J Biol. 2003. PMID: 14690544 Free PMC article. Review.

5

Trim5alpha protein restricts both HIV-1 and murine leukemia virus.

Yap MW, Nisole S, Lynch C, Stoye JP. Yap MW, et al. Proc Natl Acad Sci U S A. 2004 Jul 20;101(29):10786-91. doi: 10.1073/pnas.0402876101. Epub 2004 Jul 12. Proc Natl Acad Sci U S A. 2004. PMID: 15249690 Free PMC article.

6

A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction.

Yap MW, Nisole S, Stoye JP. Yap MW, et al. Curr Biol. 2005 Jan 11;15(1):73-8. doi: 10.1016/j.cub.2004.12.042. Curr Biol. 2005. PMID: 15649369 Free article.

7

Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.

Dodding MP, Bock M, Yap MW, Stoye JP. Dodding MP, et al. Among authors: yap mw. J Virol. 2005 Aug;79(16):10571-7. doi: 10.1128/JVI.79.16.10571-10577.2005. J Virol. 2005. PMID: 16051849 Free PMC article.

8

Trim-cyclophilin A fusion proteins can restrict human immunodeficiency virus type 1 infection at two distinct phases in the viral life cycle.

Yap MW, Dodding MP, Stoye JP. Yap MW, et al. J Virol. 2006 Apr;80(8):4061-7. doi: 10.1128/JVI.80.8.4061-4067.2006. J Virol. 2006. PMID: 16571822 Free PMC article.

9

Characterization of an amino-terminal dimerization domain from retroviral restriction factor Fv1.

Bishop KN, Mortuza GB, Howell S, Yap MW, Stoye JP, Taylor IA. Bishop KN, et al. Among authors: yap mw. J Virol. 2006 Aug;80(16):8225-35. doi: 10.1128/JVI.00395-06. J Virol. 2006. PMID: 16873278 Free PMC article.

10

The design of artificial retroviral restriction factors.

Yap MW, Mortuza GB, Taylor IA, Stoye JP. Yap MW, et al. Virology. 2007 Sep 1;365(2):302-14. doi: 10.1016/j.virol.2007.04.005. Epub 2007 May 9. Virology. 2007. PMID: 17493656 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters